Table 2.
Patient characteristics
| Total (%) | |
|---|---|
| N | 127 |
|
| |
| Education | |
|
| |
| ≤High School | 44 (35%) |
| > High School | 83 (65%) |
|
| |
| Gender | |
|
| |
| Male | 52 (41%) |
| Female | 75 (59%) |
|
| |
| Racial/Ethnic Subgroup | |
|
| |
| White/Non-Hispanic | 91 (72%) |
| African-American | 24 (19%) |
| Hispanic | 6 (5%) |
| Asian/Other | 6 (5%) |
|
| |
| Disease Site | |
|
| |
| Genitourinary Malignancies1 | 27 (21%) |
| Breast Cancers | 26 (20%) |
| Gynecologic Malignancies 2 | 23 (18%) |
| zGastrointestinal Malignancies3 | 22 (17%) |
| Hematalogic Malginancies4 | 11 (9%) |
| Lung Cancers5 | 9 (7%) |
| Head/Neck Cancers | 7 (6%) |
| Melanoma | 2 (2%) |
1
Includes patients with bladder, prostate, testicular, and kidney cancers.
2
Includes patients with leiomyosarcoma, cervical, endometrial, and ovarian cancers.
3
Includes patients with esophageal, gastric, pancreatic, adrenal, and colorectal cancers.
4
Includes patients with leukemia, multiple myeloma, and lymphoma.
5
Includes patients with non-small-cell lung cancer, small cell lung cancer, and thymoma.